25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BNOX (Bionomics) Stock Analysis
Buy, Hold or Sell?

Let's analyze Bionomics together

I guess you are interested in Bionomics Ltd ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Bionomics’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Bionomics’s Price Targets

I'm going to help you getting a better view of Bionomics Ltd ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Bionomics Ltd ADR

I send you an email if I find something interesting about Bionomics Ltd ADR.

1. Quick Overview

1.1. Quick analysis of Bionomics (30 sec.)










1.2. What can you expect buying and holding a share of Bionomics? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$8.45
Expected worth in 1 year
$16.93
How sure are you?
51.3%

+ What do you gain per year?

Total Gains per Share
$8.48
Return On Investment
169.3%

For what price can you sell your share?

Current Price per Share
$5.01
Expected price per share
$2.9 - $7.44
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Bionomics (5 min.)




Live pricePrice per Share (EOD)
$5.01
Intrinsic Value Per Share
$-182.26 - $-58.45
Total Value Per Share
$-173.81 - $-50.00

2.2. Growth of Bionomics (5 min.)




Is Bionomics growing?

Current yearPrevious yearGrowGrow %
How rich?$13.7m$18.6m-$2.5m-16.1%

How much money is Bionomics making?

Current yearPrevious yearGrowGrow %
Making money-$943.1k-$7.1m$6.1m654.4%
Net Profit Margin-368.9%-6,806.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Bionomics (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#586 / 913

Most Revenue
#554 / 913

Most Profit
#216 / 913

Most Efficient
#636 / 913
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Bionomics?

Welcome investor! Bionomics's management wants to use your money to grow the business. In return you get a share of Bionomics.

First you should know what it really means to hold a share of Bionomics. And how you can make/lose money.

Speculation

The Price per Share of Bionomics is $5.01. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bionomics.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bionomics, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $8.45. Based on the TTM, the Book Value Change Per Share is $2.12 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.56 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bionomics.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.19-23.8%-0.43-8.6%-0.50-10.0%-0.61-12.1%-0.96-19.2%
Usd Book Value Change Per Share7.35146.8%2.1242.3%-0.56-11.2%0.316.2%-0.17-3.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share7.35146.8%2.1242.3%-0.56-11.2%0.316.2%-0.17-3.5%
Usd Price Per Share3.43-1.55-2.25-2.77-1.35-
Price to Earnings Ratio-0.72--2.41--95.27--21.08--10.27-
Price-to-Total Gains Ratio0.47-0.17-312.64-106.50-106.50-
Price to Book Ratio0.41-0.30-115.53-24.87-12.12-
Price-to-Total Gains Ratio0.47-0.17-312.64-106.50-106.50-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.01
Number of shares199
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share2.120.31
Usd Total Gains Per Share2.120.31
Gains per Quarter (199 shares)422.0561.74
Gains per Year (199 shares)1,688.20246.96
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10168816780247237
20337633660494484
30506550540741731
40675367420988978
5084418430012351225
601012910118014821472
701181711806017291719
801350613494019761966
901519415182022232213
1001688216870024702460

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.03.00.00.0%0.011.00.00.0%0.019.00.00.0%0.039.00.00.0%4.085.06.04.2%
Book Value Change Per Share2.01.00.066.7%6.05.00.054.5%10.09.00.052.6%20.019.00.051.3%45.043.07.047.4%
Dividend per Share0.00.03.00.0%0.00.011.00.0%0.00.019.00.0%0.00.039.00.0%0.00.095.00.0%
Total Gains per Share2.01.00.066.7%6.05.00.054.5%10.09.00.052.6%20.019.00.051.3%45.043.07.047.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Bionomics Ltd ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--7.3542.121+247%-0.561+108%0.310+2270%-0.174+102%
Book Value Per Share--8.4486.313+34%0.930+808%3.637+132%4.927+71%
Current Ratio--2.0622.937-30%6.237-67%7.195-71%5.220-61%
Debt To Asset Ratio--0.2430.289-16%0.216+13%0.269-10%0.440-45%
Debt To Equity Ratio--0.3220.415-23%0.280+15%0.503-36%1.115-71%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--5505923.4006157262.439-11%2355703249.148-100%817469204.482-99%817469204.482-99%
Eps---1.194-0.430-64%-0.499-58%-0.609-49%-0.964-19%
Ev To Ebitda Ratio---0.4260.442-196%-139.223+32581%-47.624+11079%-47.624+11079%
Ev To Sales Ratio--2.077infnan%7605.202-100%infnan%infnan%
Free Cash Flow Per Share---2.064-0.866-58%-0.131-94%-0.650-68%-0.930-55%
Free Cash Flow To Equity Per Share---2.132-0.407-81%-0.040-98%0.182-1275%-0.232-89%
Gross Profit Margin--1.0000.274+265%1.007-1%0.888+13%0.945+6%
Intrinsic Value_10Y_max---58.448--------
Intrinsic Value_10Y_min---182.257--------
Intrinsic Value_1Y_max---2.655--------
Intrinsic Value_1Y_min---6.231--------
Intrinsic Value_3Y_max---10.419--------
Intrinsic Value_3Y_min---29.255--------
Intrinsic Value_5Y_max---21.123--------
Intrinsic Value_5Y_min---63.644--------
Market Cap8152672.800+32%5581570.4004620826.439+21%2351061543.710-100%510460052.436-99%248685666.571-98%
Net Profit Margin---2.932-3.689+26%-68.067+2221%-60.502+1963%-31.088+960%
Operating Margin---5.126-13.729+168%-59.909+1069%-57.178+1015%-29.251+471%
Operating Ratio--6.58831.967-79%70.506-91%92.569-93%48.913-87%
Pb Ratio0.593+32%0.4060.296+37%115.532-100%24.874-98%12.118-97%
Pe Ratio-1.049-46%-0.718-2.410+236%-95.270+13168%-21.084+2836%-10.271+1330%
Price Per Share5.010+32%3.4301.545+122%2.245+53%2.767+24%1.348+154%
Price To Free Cash Flow Ratio-0.607-46%-0.416-0.522+26%-133.363+31995%-28.817+6835%-14.039+3279%
Price To Total Gains Ratio0.681+32%0.4660.173+170%312.638-100%106.503-100%106.503-100%
Quick Ratio--2.0532.860-28%5.924-65%6.783-70%4.772-57%
Return On Assets---0.107-0.048-55%-0.314+193%-0.172+61%-0.156+46%
Return On Equity---0.141-0.064-54%-0.395+180%-0.236+67%-0.327+132%
Total Gains Per Share--7.3542.121+247%-0.561+108%0.310+2270%-0.174+102%
Usd Book Value--13747995.00016102910.333-15%18689464.125-26%20882575.211-34%19400021.667-29%
Usd Book Value Change Per Share--7.3542.121+247%-0.561+108%0.310+2270%-0.174+102%
Usd Book Value Per Share--8.4486.313+34%0.930+808%3.637+132%4.927+71%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--5505923.4006157262.439-11%2355703249.148-100%817469204.482-99%817469204.482-99%
Usd Eps---1.194-0.430-64%-0.499-58%-0.609-49%-0.964-19%
Usd Free Cash Flow---3358087.000-2752703.090-18%-4432196.738+32%-4022854.814+20%-3752423.905+12%
Usd Free Cash Flow Per Share---2.064-0.866-58%-0.131-94%-0.650-68%-0.930-55%
Usd Free Cash Flow To Equity Per Share---2.132-0.407-81%-0.040-98%0.182-1275%-0.232-89%
Usd Market Cap8152672.800+32%5581570.4004620826.439+21%2351061543.710-100%510460052.436-99%248685666.571-98%
Usd Price Per Share5.010+32%3.4301.545+122%2.245+53%2.767+24%1.348+154%
Usd Profit---1943349.000-943184.667-51%-7115383.750+266%-4365511.832+125%-4106549.617+111%
Usd Revenue--662715.000253883.667+161%144190.250+360%350174.526+89%857933.218-23%
Usd Total Gains Per Share--7.3542.121+247%-0.561+108%0.310+2270%-0.174+102%
 EOD+6 -2MRQTTM+17 -20YOY+17 -215Y+20 -1710Y+19 -18

3.3 Fundamental Score

Let's check the fundamental score of Bionomics Ltd ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.049
Price to Book Ratio (EOD)Between0-10.593
Net Profit Margin (MRQ)Greater than0-2.932
Operating Margin (MRQ)Greater than0-5.126
Quick Ratio (MRQ)Greater than12.053
Current Ratio (MRQ)Greater than12.062
Debt to Asset Ratio (MRQ)Less than10.243
Debt to Equity Ratio (MRQ)Less than10.322
Return on Equity (MRQ)Greater than0.15-0.141
Return on Assets (MRQ)Greater than0.05-0.107
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Bionomics Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.041
Ma 20Greater thanMa 504.968
Ma 50Greater thanMa 1004.105
Ma 100Greater thanMa 2003.811
OpenGreater thanClose4.990
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Bionomics Ltd ADR

Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia. Its lead product candidate includes BNC210, a selective negative allosteric modulator of the a7, which is in phase 3 clinical trial for the treatment of social anxiety disorder; and is phase 2b to treat post-traumatic stress disorder. The company also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. In addition, it develops NextGen, which is in preclinical trial for the treatment of multiple central nervous system indications; Kv3.1/3.2 agonist, which is in preclinical trial to treat potential cognitive deficits and negative symptoms/social withdrawal in schizophrenia and autism spectrum disorders; and Nav1.7/1.8 inhibitors which is in preclinical trial for the potential treatment of chronic pain without the liability of addiction associated with opioid treatment. The company has a collaboration with Merck & Co., Inc. to develop a7 receptor positive allosteric modulators targeting cognitive dysfunction associated with alzheimer's disease and other central nervous system conditions. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.

Fundamental data was last updated by Penke on 2025-03-19 02:13:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Bionomics earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Bionomics to theΒ Biotechnology industry mean.
  • A Net Profit Margin of -293.2%Β means thatΒ $-2.93 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bionomics Ltd ADR:

  • The MRQ is -293.2%. The company is making a huge loss. -2
  • The TTM is -368.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-293.2%TTM-368.9%+75.7%
TTM-368.9%YOY-6,806.7%+6,437.8%
TTM-368.9%5Y-6,050.2%+5,681.3%
5Y-6,050.2%10Y-3,108.8%-2,941.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-293.2%-109.6%-183.6%
TTM-368.9%-187.7%-181.2%
YOY-6,806.7%-206.2%-6,600.5%
5Y-6,050.2%-404.0%-5,646.2%
10Y-3,108.8%-526.8%-2,582.0%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Bionomics is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Bionomics to theΒ Biotechnology industry mean.
  • -10.7% Return on Assets means thatΒ Bionomics generatedΒ $-0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bionomics Ltd ADR:

  • The MRQ is -10.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.7%TTM-4.8%-5.9%
TTM-4.8%YOY-31.4%+26.5%
TTM-4.8%5Y-17.2%+12.4%
5Y-17.2%10Y-15.6%-1.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.7%-14.4%+3.7%
TTM-4.8%-14.8%+10.0%
YOY-31.4%-14.6%-16.8%
5Y-17.2%-15.6%-1.6%
10Y-15.6%-18.0%+2.4%
4.3.1.3. Return on Equity

Shows how efficient Bionomics is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Bionomics to theΒ Biotechnology industry mean.
  • -14.1% Return on Equity means Bionomics generated $-0.14Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bionomics Ltd ADR:

  • The MRQ is -14.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -6.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.1%TTM-6.4%-7.7%
TTM-6.4%YOY-39.5%+33.1%
TTM-6.4%5Y-23.6%+17.1%
5Y-23.6%10Y-32.7%+9.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.1%-17.7%+3.6%
TTM-6.4%-18.3%+11.9%
YOY-39.5%-19.2%-20.3%
5Y-23.6%-24.3%+0.7%
10Y-32.7%-26.3%-6.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Bionomics Ltd ADR.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Bionomics is operatingΒ .

  • Measures how much profit Bionomics makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Bionomics to theΒ Biotechnology industry mean.
  • An Operating Margin of -512.6%Β means the company generated $-5.13 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bionomics Ltd ADR:

  • The MRQ is -512.6%. The company is operating very inefficient. -2
  • The TTM is -1,372.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-512.6%TTM-1,372.9%+860.3%
TTM-1,372.9%YOY-5,990.9%+4,618.0%
TTM-1,372.9%5Y-5,717.8%+4,344.9%
5Y-5,717.8%10Y-2,925.1%-2,792.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-512.6%-224.0%-288.6%
TTM-1,372.9%-281.8%-1,091.1%
YOY-5,990.9%-227.6%-5,763.3%
5Y-5,717.8%-398.6%-5,319.2%
10Y-2,925.1%-512.4%-2,412.7%
4.3.2.2. Operating Ratio

Measures how efficient Bionomics is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 6.59 means that the operating costs are $6.59 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bionomics Ltd ADR:

  • The MRQ is 6.588. The company is inefficient in keeping operating costs low. -1
  • The TTM is 31.967. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ6.588TTM31.967-25.378
TTM31.967YOY70.506-38.539
TTM31.9675Y92.569-60.603
5Y92.56910Y48.913+43.656
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.5882.323+4.265
TTM31.9673.192+28.775
YOY70.5063.069+67.437
5Y92.5695.143+87.426
10Y48.9137.010+41.903
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Bionomics Ltd ADR.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Bionomics is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 2.06Β means the company has $2.06 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bionomics Ltd ADR:

  • The MRQ is 2.062. The company is able to pay all its short-term debts. +1
  • The TTM is 2.937. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.062TTM2.937-0.875
TTM2.937YOY6.237-3.300
TTM2.9375Y7.195-4.258
5Y7.19510Y5.220+1.976
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0623.741-1.679
TTM2.9373.895-0.958
YOY6.2374.507+1.730
5Y7.1955.739+1.456
10Y5.2206.099-0.879
4.4.3.2. Quick Ratio

Measures if Bionomics is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Bionomics to theΒ Biotechnology industry mean.
  • A Quick Ratio of 2.05Β means the company can pay off $2.05 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bionomics Ltd ADR:

  • The MRQ is 2.053. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.860. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.053TTM2.860-0.807
TTM2.860YOY5.924-3.064
TTM2.8605Y6.783-3.923
5Y6.78310Y4.772+2.011
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0533.086-1.033
TTM2.8603.326-0.466
YOY5.9244.362+1.562
5Y6.7835.726+1.057
10Y4.7726.427-1.655
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Bionomics Ltd ADR.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of BionomicsΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Bionomics to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.24Β means that Bionomics assets areΒ financed with 24.3% credit (debt) and the remaining percentage (100% - 24.3%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Bionomics Ltd ADR:

  • The MRQ is 0.243. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.289. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.243TTM0.289-0.045
TTM0.289YOY0.216+0.073
TTM0.2895Y0.269+0.020
5Y0.26910Y0.440-0.171
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2430.340-0.097
TTM0.2890.340-0.051
YOY0.2160.314-0.098
5Y0.2690.365-0.096
10Y0.4400.392+0.048
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Bionomics is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Bionomics to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 32.2% means that company has $0.32 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bionomics Ltd ADR:

  • The MRQ is 0.322. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.415. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.322TTM0.415-0.093
TTM0.415YOY0.280+0.135
TTM0.4155Y0.503-0.088
5Y0.50310Y1.115-0.611
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3220.399-0.077
TTM0.4150.407+0.008
YOY0.2800.384-0.104
5Y0.5030.426+0.077
10Y1.1150.460+0.655
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Bionomics generates.

  • Above 15 is considered overpriced butΒ always compareΒ Bionomics to theΒ Biotechnology industry mean.
  • A PE ratio of -0.72 means the investor is paying $-0.72Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bionomics Ltd ADR:

  • The EOD is -1.049. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.718. Based on the earnings, the company is expensive. -2
  • The TTM is -2.410. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.049MRQ-0.718-0.331
MRQ-0.718TTM-2.410+1.692
TTM-2.410YOY-95.270+92.860
TTM-2.4105Y-21.084+18.673
5Y-21.08410Y-10.271-10.812
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.049-1.906+0.857
MRQ-0.718-2.688+1.970
TTM-2.410-3.245+0.835
YOY-95.270-3.240-92.030
5Y-21.084-6.333-14.751
10Y-10.271-7.137-3.134
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bionomics Ltd ADR:

  • The EOD is -0.607. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.416. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.522. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.607MRQ-0.416-0.191
MRQ-0.416TTM-0.522+0.107
TTM-0.522YOY-133.363+132.841
TTM-0.5225Y-28.817+28.295
5Y-28.81710Y-14.039-14.778
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.607-2.455+1.848
MRQ-0.416-3.724+3.308
TTM-0.522-4.254+3.732
YOY-133.363-4.356-129.007
5Y-28.817-8.511-20.306
10Y-14.039-9.739-4.300
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Bionomics is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 0.41 means the investor is paying $0.41Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bionomics Ltd ADR:

  • The EOD is 0.593. Based on the equity, the company is cheap. +2
  • The MRQ is 0.406. Based on the equity, the company is cheap. +2
  • The TTM is 0.296. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.593MRQ0.406+0.187
MRQ0.406TTM0.296+0.110
TTM0.296YOY115.532-115.235
TTM0.2965Y24.874-24.578
5Y24.87410Y12.118+12.756
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.5931.726-1.133
MRQ0.4062.254-1.848
TTM0.2962.433-2.137
YOY115.5322.441+113.091
5Y24.8743.776+21.098
10Y12.1184.200+7.918
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Bionomics Ltd ADR.

4.8.1. Institutions holding Bionomics Ltd ADR

Institutions are holding 16.221% of the shares of Bionomics Ltd ADR.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-12-31Jane Street Group LLC0.7576013311133110
2024-12-31Merck & Co Inc0.57070.013310027100270
2024-12-31Bank of America Corp0.3690648464840
2024-12-31UBS Group AG0.16950297829780
2024-12-31Morgan Stanley - Brokerage Accounts0.000407-67-90.5405
2024-12-31Susquehanna International Group, LLP000-2845-100
2024-09-30Lewis Asset Management LLC000-23000-100
2024-12-31Rhumbline Advisers000-692-100
2024-09-30Beacon Pointe Advisors, LLC000-10000-100
2024-12-31Aspire Private Capital, LLC000-17-100
2024-09-30JPMorgan Chase & Co000-2-100
2024-12-31Armistice Capital, LLC000-132745-100
2024-09-30Two Sigma Investments LLC000-16370-100
2024-09-30XTX Topco Ltd000-10940-100
2024-09-30TWO SIGMA SECURITIES, LLC000-26038-100
2024-12-31Northwestern Mutual Wealth Management Co000-25-100
2024-12-31Point72 Asset Management, L.P.000-26332-100
Total 1.86720.013332807-216273-659.2%

4.9.2. Funds holding Bionomics Ltd ADR

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-02-28AdvisorShares Psychedelics ETF2.71252.608476591500045.9291
Total 2.71252.60847659+15000+31.5%
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-09-302023-12-312024-06-302024-09-302024-12-31
Gross Profit  -2,787-2,383-5,1694,733-436-4,733-5,1695,832663



5.2. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets18,168
Total Liabilities4,420
Total Stockholder Equity13,748
 As reported
Total Liabilities 4,420
Total Stockholder Equity+ 13,748
Total Assets = 18,168

Assets

Total Assets18,168
Total Current Assets4,399
Long-term Assets13,770
Total Current Assets
Cash And Cash Equivalents 4,345
Net Receivables 36
Other Current Assets 18
Total Current Assets  (as reported)4,399
Total Current Assets  (calculated)4,399
+/-0
Long-term Assets
Property Plant Equipment 152
Goodwill 8,407
Intangible Assets 5,136
Long-term Assets Other 74
Long-term Assets  (as reported)13,770
Long-term Assets  (calculated)13,770
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,134
Long-term Liabilities2,287
Total Stockholder Equity13,748
Total Current Liabilities
Short-term Debt 150
Short Long Term Debt 31
Accounts payable 1,531
Other Current Liabilities 453
Total Current Liabilities  (as reported)2,134
Total Current Liabilities  (calculated)2,165
+/- 31
Long-term Liabilities
Capital Lease Obligations 168
Long-term Liabilities Other 584
Long-term Liabilities  (as reported)2,287
Long-term Liabilities  (calculated)752
+/- 1,535
Total Stockholder Equity
Common Stock0
Retained Earnings -180,725
Accumulated Other Comprehensive Income -3,717
Other Stockholders Equity 198,190
Total Stockholder Equity (as reported)13,748
Total Stockholder Equity (calculated)13,748
+/-0
Other
Capital Stock0
Cash and Short Term Investments 4,345
Common Stock Shares Outstanding 1,575
Liabilities and Stockholders Equity 18,168
Net Debt -4,145
Net Invested Capital 13,779
Net Working Capital 2,265
Property Plant and Equipment Gross 152
Short Long Term Debt Total 199



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-31
> Total Assets 
0
0
0
0
0
0
0
0
0
10,829
0
0
0
15,839
0
0
3,143
12,571
3,143
11,319
3,740
14,962
3,740
13,512
4,262
17,050
4,262
21,702
4,929
19,715
4,929
21,477
7,705
30,821
7,705
26,250
7,078
28,313
7,078
24,713
6,181
24,725
6,181
34,875
7,879
31,514
7,879
26,481
8,577
34,309
8,577
28,650
7,776
31,102
7,776
39,046
13,403
53,611
13,403
52,275
16,265
65,061
16,265
72,177
17,283
69,132
17,283
92,584
22,003
88,010
22,003
79,715
21,019
84,075
21,019
75,115
16,266
65,066
16,266
62,690
13,415
37,672
13,415
30,989
8,616
23,784
8,616
23,229
13,566
40,689
13,566
49,293
16,328
65,310
45,091
38,333
16,328
24,976
28,643
26,481
27,649
22,917
18,168
18,16822,91727,64926,48128,64324,97616,32838,33345,09165,31016,32849,29313,56640,68913,56623,2298,61623,7848,61630,98913,41537,67213,41562,69016,26665,06616,26675,11521,01984,07521,01979,71522,00388,01022,00392,58417,28369,13217,28372,17716,26565,06116,26552,27513,40353,61113,40339,0467,77631,1027,77628,6508,57734,3098,57726,4817,87931,5147,87934,8756,18124,7256,18124,7137,07828,3137,07826,2507,70530,8217,70521,4774,92919,7154,92921,7024,26217,0504,26213,5123,74014,9623,74011,3193,14312,5713,1430015,83900010,829000000000
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
9,964
0
0
0
8,833
0
0
1,551
6,203
1,551
5,134
2,243
8,971
2,243
7,659
2,360
9,438
2,360
6,920
1,290
5,158
1,290
7,450
3,489
13,955
3,489
9,461
2,214
8,856
2,214
5,262
1,472
5,888
1,472
16,639
3,474
13,896
3,474
16,775
6,222
24,886
6,222
19,086
5,435
21,738
5,435
17,300
7,679
30,715
7,679
25,031
9,880
39,518
9,880
44,073
9,470
37,881
9,470
61,120
14,521
58,086
14,521
49,985
13,620
54,478
13,620
46,273
8,980
35,920
8,980
33,297
6,283
17,644
6,283
12,051
2,083
5,751
2,083
5,146
7,732
23,191
7,732
32,405
10,453
41,810
28,867
22,568
10,453
10,836
13,385
11,489
13,194
8,429
4,399
4,3998,42913,19411,48913,38510,83610,45322,56828,86741,81010,45332,4057,73223,1917,7325,1462,0835,7512,08312,0516,28317,6446,28333,2978,98035,9208,98046,27313,62054,47813,62049,98514,52158,08614,52161,1209,47037,8819,47044,0739,88039,5189,88025,0317,67930,7157,67917,3005,43521,7385,43519,0866,22224,8866,22216,7753,47413,8963,47416,6391,4725,8881,4725,2622,2148,8562,2149,4613,48913,9553,4897,4501,2905,1581,2906,9202,3609,4382,3607,6592,2438,9712,2435,1341,5516,2031,551008,8330009,964000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
1
0
0
0
8,592
0
0
1,518
6,070
1,518
4,957
2,176
8,703
2,176
7,443
2,251
9,005
2,251
6,389
1,182
4,728
1,182
7,003
3,205
12,821
3,205
8,889
1,570
6,280
1,570
4,332
1,189
4,757
1,189
16,030
3,153
12,612
3,153
8,475
4,013
16,052
4,013
17,886
4,334
17,337
4,334
9,289
5,613
22,452
5,613
20,471
2,625
10,500
2,625
38,369
6,640
26,558
6,640
51,408
11,363
45,450
11,363
43,122
10,718
42,874
10,718
32,021
6,233
24,930
6,233
27,355
3,496
9,819
3,496
6,042
1,144
3,159
1,144
4,425
7,125
21,370
7,125
29,319
8,391
33,565
23,174
20,899
8,391
9,557
12,155
10,132
12,608
8,082
4,345
4,3458,08212,60810,13212,1559,5578,39120,89923,17433,5658,39129,3197,12521,3707,1254,4251,1443,1591,1446,0423,4969,8193,49627,3556,23324,9306,23332,02110,71842,87410,71843,12211,36345,45011,36351,4086,64026,5586,64038,3692,62510,5002,62520,4715,61322,4525,6139,2894,33417,3374,33417,8864,01316,0524,0138,4753,15312,6123,15316,0301,1894,7571,1894,3321,5706,2801,5708,8893,20512,8213,2057,0031,1824,7281,1826,3892,2519,0052,2517,4432,1768,7032,1764,9571,5186,0701,518008,5920001000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7
0
7
0
7
0
7
0
9
0
9
36
9
0
9
0
0
0
0
0
138
0
138
550
138
0
138
550
138
550
138
550
138
550
138
550
138
550
138
550
138
0
138
0
109
0
109
327
109
0
109
0
0
0
7
0
0
0
0
0
0
0000007000109010932710901090138013855013855013855013855013855013855013855013801385501380138000009093690907070707000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
85
0
0
0
99
0
0
7
27
7
107
34
135
34
113
35
141
35
380
61
242
61
219
85
339
85
409
579
2,315
579
701
194
775
194
455
212
847
212
805
2,112
8,449
2,112
766
103
411
103
7,392
176
706
176
4,193
5,185
20,740
5,185
4,554
266
1,064
266
2,985
2,751
11,003
2,751
1,156
2,473
9,893
2,473
998
178
713
178
1,114
222
569
222
29
15
12
15
21
50
145
50
18
1,696
6,784
4,665
26
1,696
643
428
424
85
116
36
36116854244286431,696264,6656,7841,69618501455021151215292225692221,1141787131789982,4739,8932,4731,1562,75111,0032,7512,9852661,0642664,5545,18520,7405,1854,1931767061767,3921034111037662,1128,4492,1128052128472124551947751947015792,31557940985339852196124261380351413511334135341077277009900085000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
26
0
0
0
68
0
0
26
34
26
70
33
56
33
103
65
9
65
111
36
35
36
198
174
593
174
128
45
38
45
88
58
7
58
79
74
26
74
88
86
96
86
355
955
3,109
955
258
1,865
7,000
1,865
262
2,048
7,515
2,048
678
2,325
8,105
2,325
6,336
161
0
161
4,729
184
3
184
12,263
2,309
8,284
2,309
3,754
2,261
6,790
2,261
5,979
924
2,579
924
700
448
1,676
448
3,068
365
1,461
5,693
1,643
365
1,279
1,229
933
459
231
18
182314599331,2291,2793651,6435,6931,4613653,0684481,6764487009242,5799245,9792,2616,7902,2613,7542,3098,2842,30912,26318431844,72916101616,3362,3258,1052,3256782,0487,5152,0482621,8657,0001,8652589553,109955355869686887426747958758884538451281745931741983635361116596510333563370263426006800026000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
866
0
0
0
7,006
0
0
1,592
6,367
1,592
6,185
1,498
5,991
1,498
5,853
1,903
7,611
1,903
14,782
3,639
14,557
3,639
14,026
4,216
16,866
4,216
16,789
4,864
19,457
4,864
19,451
4,709
18,837
4,709
18,236
4,405
17,618
4,405
9,706
2,356
9,423
2,356
9,564
2,341
9,364
2,341
21,746
5,724
22,896
5,724
27,244
6,386
25,543
6,386
28,104
7,813
31,251
7,813
31,464
7,481
29,924
7,481
29,730
7,399
29,597
7,399
28,842
7,286
29,146
7,286
29,393
7,132
19,758
7,132
18,939
6,532
17,732
6,532
18,083
5,834
17,410
5,834
16,802
5,875
23,500
16,143
15,765
5,875
14,140
15,179
14,911
14,455
14,488
13,770
13,77014,48814,45514,91115,17914,1405,87515,76516,14323,5005,87516,8025,83417,4105,83418,0836,53217,7326,53218,9397,13219,7587,13229,3937,28629,1467,28628,8427,39929,5977,39929,7307,48129,9247,48131,4647,81331,2517,81328,1046,38625,5436,38627,2445,72422,8965,72421,7462,3419,3642,3419,5642,3569,4232,3569,7064,40517,6184,40518,2364,70918,8374,70919,4514,86419,4574,86416,7894,21616,8664,21614,0263,63914,5573,63914,7821,9037,6111,9035,8531,4985,9911,4986,1851,5926,3671,592007,006000866000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
724
0
0
0
6,906
0
0
1,578
6,311
1,578
6,149
1,494
5,977
1,494
5,853
1,414
5,654
1,414
5,723
1,411
5,646
1,411
5,428
2,157
8,628
2,157
8,661
2,154
8,618
2,154
8,476
2,095
8,379
2,095
8,140
1,977
7,908
1,977
319
76
303
76
764
193
773
193
778
211
843
211
793
207
828
207
1,327
863
3,451
863
3,325
709
2,835
709
2,740
654
2,618
654
2,763
686
2,744
686
2,732
627
1,760
627
1,100
264
728
264
504
218
653
218
552
169
675
466
401
169
267
335
284
219
199
152
1521992192843352671694014666751695522186532185042647282641,1006271,7606272,7326862,7446862,7636542,6186542,7407092,8357093,3258633,4518631,32720782820779321184321177819377319376476303763191,9777,9081,9778,1402,0958,3792,0958,4762,1548,6182,1548,6612,1578,6282,1575,4281,4115,6461,4115,7231,4145,6541,4145,8531,4945,9771,4946,1491,5786,3111,578006,906000724000000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
489
0
489
1,956
489
0
544
2,177
544
0
532
2,127
532
0
1,287
5,148
1,287
0
1,287
5,148
1,287
0
1,287
5,148
1,287
0
1,287
5,148
1,287
0
1,287
5,148
1,287
0
1,287
5,148
1,287
0
2,372
9,488
2,372
0
2,622
10,489
2,622
0
2,661
10,642
2,661
0
3,066
12,264
3,066
0
3,117
12,470
3,117
0
3,190
8,959
3,190
8,963
3,218
8,884
3,218
9,448
3,100
9,299
3,100
9,132
3,217
12,868
8,884
8,819
3,217
8,324
8,715
8,825
8,690
8,904
8,407
8,4078,9048,6908,8258,7158,3243,2178,8198,88412,8683,2179,1323,1009,2993,1009,4483,2188,8843,2188,9633,1908,9593,19003,11712,4703,11703,06612,2643,06602,66110,6422,66102,62210,4892,62202,3729,4882,37201,2875,1481,28701,2875,1481,28701,2875,1481,28701,2875,1481,28701,2875,1481,28701,2875,1481,28705322,12753205442,17754404891,95648904890000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
119
0
164
0
0
0
119
0
0
0
119
0
0
0
000119000119000164011900000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
142
0
0
0
99
0
0
14
57
14
35
4
14
4
0
0
1
0
9,059
1,684
6,734
1,684
8,598
1,528
6,110
1,528
8,128
1,423
5,691
1,423
10,975
1,328
5,310
1,328
10,096
1,141
4,563
1,141
9,386
993
3,972
993
8,800
843
3,372
843
20,898
4,226
16,905
4,226
26,451
3,806
15,226
3,806
26,777
4,232
16,928
4,232
27,755
4,016
16,063
4,016
26,606
3,583
14,331
3,583
25,695
3,387
13,548
3,387
26,277
3,219
9,038
3,219
8,570
2,942
8,120
2,942
7,794
2,486
7,458
2,486
7,118
2,460
9,838
6,793
6,464
2,460
5,472
6,129
5,802
5,468
5,302
5,136
5,1365,3025,4685,8026,1295,4722,4606,4646,7939,8382,4607,1182,4867,4582,4867,7942,9428,1202,9428,5703,2199,0383,21926,2773,38713,5483,38725,6953,58314,3313,58326,6064,01616,0634,01627,7554,23216,9284,23226,7773,80615,2263,80626,4514,22616,9054,22620,8988433,3728438,8009933,9729939,3861,1414,5631,14110,0961,3285,3101,32810,9751,4235,6911,4238,1281,5286,1101,5288,5981,6846,7341,6849,05901004144351457140099000142000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
119
0
119
0
119
119
82
0
119
119
79
81
0
0
0
0008179119119082119119011901190000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
0
0
0
0
0
0
642
0
0
0
5,850
0
0
1,464
5,856
1,464
6,392
1,508
6,031
1,508
6,386
1,593
6,371
1,593
8,500
2,192
8,768
2,192
8,405
2,031
8,122
2,031
6,767
1,696
6,786
1,696
6,740
1,508
6,030
1,508
5,304
1,512
6,049
1,512
5,679
1,402
5,610
1,402
3,352
1,301
5,203
1,301
9,266
3,051
12,204
3,051
16,649
5,061
20,242
5,061
31,685
9,291
37,166
9,291
43,181
11,394
45,577
11,394
43,529
10,905
43,621
10,905
43,605
12,027
48,108
12,027
46,026
8,990
26,088
8,990
23,069
5,445
15,032
5,445
10,831
1,666
4,998
1,666
5,493
2,099
8,397
5,798
5,847
2,099
6,312
6,565
6,693
10,159
5,847
4,420
4,4205,84710,1596,6936,5656,3122,0995,8475,7988,3972,0995,4931,6664,9981,66610,8315,44515,0325,44523,0698,99026,0888,99046,02612,02748,10812,02743,60510,90543,62110,90543,52911,39445,57711,39443,1819,29137,1669,29131,6855,06120,2425,06116,6493,05112,2043,0519,2661,3015,2031,3013,3521,4025,6101,4025,6791,5126,0491,5125,3041,5086,0301,5086,7401,6966,7861,6966,7672,0318,1222,0318,4052,1928,7682,1928,5001,5936,3711,5936,3861,5086,0311,5086,3921,4645,8561,464005,850000642000000000
   > Total Current Liabilities 
0
0
0
0
0
0
0
0
0
592
0
0
0
843
0
0
307
1,230
307
1,766
351
1,405
351
1,760
509
2,035
509
2,165
670
2,681
670
2,609
903
3,613
903
2,847
763
3,051
763
3,174
698
2,791
698
2,324
809
3,236
809
3,059
1,370
5,480
1,370
2,840
1,117
4,468
1,117
3,839
1,521
6,083
1,521
5,385
2,320
9,281
2,320
8,191
3,426
13,706
3,426
14,601
2,847
11,386
2,847
12,590
3,472
13,889
3,472
7,497
3,321
13,285
3,321
13,368
3,451
9,690
3,451
10,902
2,068
5,709
2,068
7,001
590
1,770
590
2,408
839
3,356
2,317
2,493
839
2,843
2,750
3,015
3,829
2,552
2,134
2,1342,5523,8293,0152,7502,8438392,4932,3173,3568392,4085901,7705907,0012,0685,7092,06810,9023,4519,6903,45113,3683,32113,2853,3217,4973,47213,8893,47212,5902,84711,3862,84714,6013,42613,7063,4268,1912,3209,2812,3205,3851,5216,0831,5213,8391,1174,4681,1172,8401,3705,4801,3703,0598093,2368092,3246982,7916983,1747633,0517632,8479033,6139032,6096702,6816702,1655092,0355091,7603511,4053511,7663071,23030700843000592000000000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
22
0
0
0
127
0
0
127
508
127
508
127
508
127
508
90
358
90
371
96
414
96
429
123
542
123
559
143
572
143
614
132
529
132
535
157
627
157
547
707
2,828
707
691
183
733
183
709
170
680
170
685
197
789
197
2,349
1,365
5,460
1,365
5,231
969
3,874
969
6,894
2,124
8,496
2,124
1,888
1,458
5,834
1,458
8,532
2,113
5,931
2,113
6,070
1,296
4,099
1,296
5,733
1,296
131
0
112
0
160
110
112
127
722
114
885
122
165
150
150165122885114722127112110160011201311,2965,7331,2964,0991,2966,0702,1135,9312,1138,5321,4585,8341,4581,8882,1248,4962,1246,8949693,8749695,2311,3655,4601,3652,3491977891976851706801707091837331836917072,828707547157627157535132529132614143572143559123542123429964149637190358905081275081275081275081270012700022000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33
0
1,123
0
35
31
313501,1230330000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
154
0
0
0
345
0
0
88
350
88
672
131
524
131
796
239
958
239
1,335
269
1,077
269
1,521
530
2,120
530
1,895
431
1,725
431
1,923
284
1,137
284
1,174
346
1,384
346
1,828
339
1,357
339
1,400
498
1,991
498
2,177
818
3,272
818
3,458
666
2,663
666
2,582
983
3,933
983
5,111
658
2,633
658
3,623
475
1,900
475
3,955
902
3,607
902
3,417
301
844
301
749
315
871
315
939
257
771
257
2,000
389
1,557
1,075
2,104
389
1,648
1,374
1,746
2,244
1,326
1,531
1,5311,3262,2441,7461,3741,6483892,1041,0751,5573892,0002577712579393158713157493018443013,4179023,6079023,9554751,9004753,6236582,6336585,1119833,9339832,5826662,6636663,4588183,2728182,1774981,9914981,4003391,3573391,8283461,3843461,1742841,1372841,9234311,7254311,8955302,1205301,5212691,0772691,335239958239796131524131672883508800345000154000000000
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
366
0
0
0
248
0
0
88
351
88
586
81
323
81
456
141
563
141
460
251
1,945
251
660
223
1,683
223
394
128
1,026
128
637
255
2,042
255
614
288
2,308
288
685
312
2,494
312
748
432
3,452
432
953
523
2,092
523
1,242
640
2,561
640
3,261
1,059
4,237
1,059
4,259
1,203
4,813
1,203
2,073
868
3,473
868
1,654
939
7,512
939
1,419
981
8,846
981
10,153
400
4,838
456
6,062
-963
999
333
407
450
3,438
1,242
388
450
474
3
383
1,463
1,061
453
4531,0611,46338334744503881,2423,438450407333999-9636,0624564,83840010,1539818,8469811,4199397,5129391,6548683,4738682,0731,2034,8131,2034,2591,0594,2371,0593,2616402,5616401,2425232,0925239534323,4524327483122,4943126852882,3082886142552,0422556371281,0261283942231,6832236602511,9452514601415631414568132381586883518800248000366000000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
50
0
0
0
5,007
0
0
1,156
4,626
1,156
4,626
1,156
4,626
1,156
4,626
1,084
4,335
1,084
6,335
1,522
6,087
1,522
5,796
1,127
4,509
1,127
3,920
934
3,735
934
3,566
810
3,239
810
2,980
703
2,813
703
2,620
32
130
32
513
184
735
184
5,427
1,530
6,122
1,530
11,264
2,740
10,961
2,740
23,493
5,865
23,460
5,865
28,580
8,548
34,191
8,548
30,938
7,433
29,733
7,433
36,108
8,706
34,823
8,706
32,658
5,540
6,913
5,540
3,306
3,377
4,320
3,377
1,752
1,076
4,305
1,076
4,247
1,260
5,042
3,467
3,341
1,260
3,469
3,812
3,682
6,330
3,295
2,287
2,2873,2956,3303,6823,8123,4691,2603,3413,4675,0421,2604,2471,0764,3051,0761,7523,3774,3203,3773,3065,5406,9135,54032,6588,70634,8238,70636,1087,43329,7337,43330,9388,54834,1918,54828,5805,86523,4605,86523,4932,74010,9612,74011,2641,5306,1221,5305,42718473518451332130322,6207032,8137032,9808103,2398103,5669343,7359343,9201,1274,5091,1275,7961,5226,0871,5226,3351,0844,3351,0844,6261,1564,6261,1564,6261,1564,6261,156005,00700050000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,695
2,695
3,612
3,612
3,632
3,632
4,508
4,508
4,478
4,478
5,365
5,365
0
0
0
0
0
000005,3655,3654,4784,4784,5084,5083,6323,6323,6123,6122,6952,69500000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
0
0
0
0
0
0
10,187
0
0
0
9,989
0
0
1,679
6,715
1,679
4,927
2,233
8,931
2,233
7,126
2,670
10,679
2,670
13,203
2,737
10,946
2,737
13,071
5,675
22,699
5,675
19,482
5,382
21,527
5,382
17,972
4,674
18,695
4,674
29,571
6,366
25,466
6,366
20,802
7,175
28,699
7,175
25,298
6,475
25,899
6,475
29,780
10,352
41,407
10,352
35,626
11,205
44,819
11,205
40,492
7,991
31,966
7,991
49,403
10,608
42,433
10,608
36,187
10,113
40,454
10,113
31,510
4,239
16,958
4,239
16,664
4,425
11,583
4,425
7,921
3,171
8,752
3,171
12,398
11,899
35,691
11,899
43,800
14,228
56,913
39,294
32,486
14,228
18,664
22,078
19,788
17,490
17,070
13,748
13,74817,07017,49019,78822,07818,66414,22832,48639,29456,91314,22843,80011,89935,69111,89912,3983,1718,7523,1717,9214,42511,5834,42516,6644,23916,9584,23931,51010,11340,45410,11336,18710,60842,43310,60849,4037,99131,9667,99140,49211,20544,81911,20535,62610,35241,40710,35229,7806,47525,8996,47525,2987,17528,6997,17520,8026,36625,4666,36629,5714,67418,6954,67417,9725,38221,5275,38219,4825,67522,6995,67513,0712,73710,9462,73713,2032,67010,6792,6707,1262,2338,9312,2334,9271,6796,7151,679009,98900010,187000000000
   Common Stock
0
0
0
0
0
0
0
0
0
15,806
0
0
0
19,098
0
0
5,091
20,365
5,091
20,412
6,539
26,155
6,539
26,308
8,198
32,792
8,198
38,010
9,509
38,038
9,509
42,975
13,209
52,834
13,209
53,045
14,025
56,099
14,025
56,289
14,992
59,970
14,992
74,977
18,779
75,114
18,779
75,138
21,923
87,691
21,923
87,702
21,959
87,835
21,959
95,545
27,828
111,313
27,828
111,650
27,930
111,722
27,930
111,754
27,998
111,990
27,998
134,345
33,598
134,393
33,598
134,517
33,634
134,536
33,634
134,820
33,803
135,212
33,803
145,365
36,236
101,758
36,236
101,701
37,039
102,247
37,039
117,449
47,548
142,614
47,548
155,668
54,424
217,696
150,301
152,156
54,424
150,311
148,803
159,367
0
0
0
000159,367148,803150,31154,424152,156150,301217,69654,424155,66847,548142,61447,548117,44937,039102,24737,039101,70136,236101,75836,236145,36533,803135,21233,803134,82033,634134,53633,634134,51733,598134,39333,598134,34527,998111,99027,998111,75427,930111,72227,930111,65027,828111,31327,82895,54521,95987,83521,95987,70221,92387,69121,92375,13818,77975,11418,77974,97714,99259,97014,99256,28914,02556,09914,02553,04513,20952,83413,20942,9759,50938,0389,50938,0108,19832,7928,19826,3086,53926,1556,53920,4125,09120,3655,0910019,09800015,806000000000
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-314
0
-314
0
-418
0
-418
0
-531
-256
-531
199
-668
434
-668
492
-638
2,839
-638
3,041
-725
3,188
-725
3,620
-812
3,347
-812
3,273
-762
3,187
-762
3,036
-476
695
-476
747
-490
887
-490
1,097
-556
2,919
-556
3,636
-589
2,715
-589
4,032
-706
6,543
-706
11,316
-758
11,216
-758
14,542
-871
14,113
-871
13,732
-979
13,098
-979
13,661
-1,039
13,620
-1,039
13,433
-460
13,414
-460
9,188
-402
11,448
-402
10,732
-63
12,524
8,612
9,119
-63
8,894
9,656
9,440
-3,014
-2,428
-3,717
-3,717-2,428-3,0149,4409,6568,894-639,1198,61212,524-6310,732-40211,448-4029,188-46013,414-46013,433-1,03913,620-1,03913,661-97913,098-97913,732-87114,113-87114,542-75811,216-75811,316-7066,543-7064,032-5892,715-5893,636-5562,919-5561,097-490887-490747-476695-4763,036-7623,187-7623,273-8123,347-8123,620-7253,188-7253,041-6382,839-638492-668434-668199-531-256-5310-4180-4180-3140-3140000000000000000
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
314
0
314
0
418
0
418
0
467
0
467
0
776
0
776
0
1,348
0
1,348
0
1,522
0
1,522
0
1,649
0
1,649
0
1,559
0
1,559
0
650
0
650
0
712
0
712
0
1,285
0
1,285
0
1,267
0
1,267
0
2,342
0
2,342
0
3,562
0
3,562
0
4,399
0
4,399
0
4,254
0
4,254
0
4,443
9,562
4,443
9,426
3,813
9,257
3,813
7,084
3,264
8,584
3,264
7,798
3,194
12,524
35
35
14,506
14,506
6
-11
198,481
198,280
198,190
198,190198,280198,481-11614,50614,506353512,5243,1947,7983,2648,5843,2647,0843,8139,2573,8139,4264,4439,5624,44304,25404,25404,39904,39903,56203,56202,34202,34201,26701,26701,28501,285071207120650065001,55901,55901,64901,64901,52201,52201,34801,348077607760467046704180418031403140000000000000000



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue20
Cost of Revenue-434
Gross Profit-434-414
 
Operating Income (+$)
Gross Profit-434
Operating Expense-17,892,376
Operating Income-17,892,376-17,892,810
 
Operating Expense (+$)
Research Development9,417,785
Selling General Administrative8,474,591
Selling And Marketing Expenses147
Operating Expense17,892,37617,892,523
 
Net Interest Income (+$)
Interest Income220
Interest Expense-20
Other Finance Cost-20
Net Interest Income220
 
Pretax Income (+$)
Operating Income-17,892,376
Net Interest Income220
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-10,271-35,774,481
EBIT - interestExpense = -10,291
-15,579,486
-15,492,146
Interest Expense20
Earnings Before Interest and Taxes (EBIT)-10,271-10,251
Earnings Before Interest and Taxes (EBITDA)-9,837
 
After tax Income (+$)
Income Before Tax-10,271
Tax Provision--87
Net Income From Continuing Ops-15,492-10,184
Net Income-15,492,166
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses17,892,376
Total Other Income/Expenses Net17,882,105-220
 

Technical Analysis of Bionomics
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bionomics. The general trend of Bionomics is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bionomics's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Bionomics Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bionomics Ltd ADR.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 6.39 < 6.9 < 7.44.

The bearish price targets are: 4.17 > 3 > 2.9.

Know someone who trades $BNOX? Share this with them.πŸ‘‡

Bionomics Ltd ADR Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bionomics Ltd ADR. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bionomics Ltd ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bionomics Ltd ADR. The current macd is 0.26519511.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bionomics price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Bionomics. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Bionomics price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Bionomics Ltd ADR Daily Moving Average Convergence/Divergence (MACD) ChartBionomics Ltd ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bionomics Ltd ADR. The current adx is 68.06.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Bionomics shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Bionomics Ltd ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bionomics Ltd ADR. The current sar is 9.86779638.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Bionomics Ltd ADR Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bionomics Ltd ADR. The current rsi is 57.04. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Bionomics Ltd ADR Daily Relative Strength Index (RSI) ChartBionomics Ltd ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bionomics Ltd ADR. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bionomics price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Bionomics Ltd ADR Daily Stochastic Oscillator ChartBionomics Ltd ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bionomics Ltd ADR. The current cci is -22.31755437.

Bionomics Ltd ADR Daily Commodity Channel Index (CCI) ChartBionomics Ltd ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bionomics Ltd ADR. The current cmo is 13.10.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Bionomics Ltd ADR Daily Chande Momentum Oscillator (CMO) ChartBionomics Ltd ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bionomics Ltd ADR. The current willr is -43.23940807.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Bionomics is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Bionomics Ltd ADR Daily Williams %R ChartBionomics Ltd ADR Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Bionomics Ltd ADR.

Bionomics Ltd ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bionomics Ltd ADR. The current atr is 0.77807855.

Bionomics Ltd ADR Daily Average True Range (ATR) ChartBionomics Ltd ADR Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bionomics Ltd ADR. The current obv is 83,469,036.

Bionomics Ltd ADR Daily On-Balance Volume (OBV) ChartBionomics Ltd ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bionomics Ltd ADR. The current mfi is 73.03.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Bionomics Ltd ADR Daily Money Flow Index (MFI) ChartBionomics Ltd ADR Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bionomics Ltd ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-10-01MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-25MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-02MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-01-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-27BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-01-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-24STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Bionomics Ltd ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bionomics Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.041
Ma 20Greater thanMa 504.968
Ma 50Greater thanMa 1004.105
Ma 100Greater thanMa 2003.811
OpenGreater thanClose4.990
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Bionomics with someone you think should read this too:
  • Are you bullish or bearish on Bionomics? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bionomics? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bionomics Ltd ADR

I send you an email if I find something interesting about Bionomics Ltd ADR.


Comments

How you think about this?

Leave a comment

Stay informed about Bionomics Ltd ADR.

Receive notifications about Bionomics Ltd ADR in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.